Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

ABVC Out-licenses China Rights for Two Neurologic Therapies to Xinnovation  

publication date: Aug 2, 2023

ABVC Biopharma of Fremont, California out-licensed China rights for two neurologic therapies to Xinnovation Therapeutics, a Jiaxing City biopharma. The two plant-based candidates, both of which are clinical-stage norepinephrine transporter inhibitors, are ABV-1504 for Major Depressive Disorder and ABV-1505 for Attention-Deficit/Hyperactivity Disorder. ABVC has completed Phase II trials for ABV-1504, while ABV-1505 is finishing a Phase II trial. Xinnovation, which will be responsible for all China clinical studies, will make royalty payments of 5% to 12% to ABVC that could total $50 million per year. More details....

Stock Symbol: (NSDQ: ABVC)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital